跳至主要内容
临床试验/NCT01231126
NCT01231126已完成4 期

Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour

Maternidade Escola Assis Chateaubriand1 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2008年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
161
试验地点
1
主要终点
Vaginal delivery

研究概览

简要总结

The purpose of this study is to evaluate the blood loss in induced vaginal delivery by misoprostol and caesarians section with induction attempt.

详细描述

Methods: it was a study achieved with 101 pregnant women with indication to induced delivery labor that were evaluated by the hemoglobin dosage pre and post delivery for estimate the blood loss at delivery. Patients were submitted to transabdominal obstetric ultrasound and basal cardiotocography. Procedures were taken for induced labor delivery with misoprostol 25mcg, by vaginal rout. The pills were administered each 6 hours in a maximum number of six. The control group was formed by 30 patients that began an spontaneously labor and 30 patients that achieved caesarians electively. The study of hemoglobin before and after delivery was evaluated through ANOVA to repeated measures, where it was verified the time effect (pre and post delivery) and the effect of the group (with and without use of misoprostol).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Indication of early elective delivery by induction of labor (pre-eclampsia, HELLP syndrome, chronic hypertension, prolonged gestation, diabetes mellitus, gestational diabetes, heart disease, thyroid disease;
  • pregnancy with living fetus;
  • vertex cephalic presentation;
  • estimated fetal weight by ultrasound > 2500g and <4000g;
  • Amniotic fluid index (AFI)> 5 cm, except in cases of premature rupture of membranes in which AFI <5 cm would be allowed;
  • cardiotocography (CTG) antepartum normal;
  • Bishop Score less than or equal to 6;
  • Determination of hemoglobin pre and post-partum.

排除标准

  • Prior Cesarean section;
  • previous uterine scar by myomectomy;
  • Fetal presentation anomalous;
  • Evidence of fetal abnormal (CTG, Ultrasound or Doppler);
  • Fetal growth restriction;
  • Gestation multiple;
  • genital bleeding;
  • tumors, malformations and / or ulceration in the region vulvoperineal and birth canal;
  • No determination of hemoglobin pre-and post-partum;

研究组 & 干预措施

spontaneous vaginal deliveries

Placebo Comparator

干预措施: Misoprostol (Drug)

elective caesarians

Placebo Comparator

干预措施: Misoprostol (Drug)

induced vaginal delivery by misoprostol

Experimental

干预措施: Misoprostol (Drug)

caesarians section with induction attempt

Experimental

干预措施: Misoprostol (Drug)

结局指标

主要结局

Vaginal delivery

时间窗: 54 hours after the first pills

Procedures were taken for induced labor delivery with misoprostol 25mcg, by vaginal rout. The pills were administered each 6 hours in a maximum number of six.

次要结局

  • blood loss(24 hours after delivery)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验